Europe · Wires & real time · Reuters US Markets

India's Cipla misses second-quarter profit view on muted US sales

Published by Reuters US Markets · United Kingdom 13 h ago

Cipla , India's third-largest drugmaker by revenue, missed second-quarter ‌profit estimates on Tuesday, as muted sales of generic Revlimid and stiff ⁠competition weighed on…

Read the full article on Reuters US Markets Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

TASS

Attempts to exclude Russian from gas market have serious consequences

Anadolu Agency

ByteDance founder Zhang Yiming regains top spot on China’s rich list amid AI boom

Reuters Asia Markets

Who's exposed to Indonesia's market meltdown?

Reuters Europe Markets

Norway's prime minister, Finland's president in phone call with Putin

Reuters Technology

Initial global sales of Apple iPhone 18 Pro higher than 17 series - Counterpoint Research

Reuters Breakingviews